GoodRx Holdings (GDRX) Operating Leases (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Operating Leases data on file, last reported at $49.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 9.28% year-over-year to $49.0 million; the trailing twelve-month figure through Mar 2026 stood at $49.0 million (up 9.28% YoY), and the FY2025 full-year result was $49.8 million, up 8.14% from the prior year.
• Operating Leases declined to $49.0 million in Q1 2026, from $49.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $56.3 million in Q1 2023 to a low of $32.5 million in Q1 2022.
• A 5-year average of $47.4 million and a median of $49.3 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases surged 73.1% in 2023 and slipped 12.75% in 2025, its largest moves.
• Tracing GDRX's Operating Leases over 5 years: stood at $54.1 million in 2022, then decreased by 10.58% to $48.4 million in 2023, then decreased by 4.88% to $46.0 million in 2024, then rose by 8.14% to $49.8 million in 2025, then slipped by 1.68% to $49.0 million in 2026.
• Business Quant data shows GDRX's Operating Leases at $49.0 million in Q1 2026, $49.8 million in Q4 2025, and $51.3 million in Q3 2025.